Request Your Free eBook Now:

"Accelerate drug discovery with generative AI"

The drug discovery process is arduous and expensive, with a mere 10-12% of candidates succeeding, according to research by the Congressional Budget Office. This e-book reveals how Rescale, with AWS and NVIDIA, is aiding companies in tackling early research and clinical trial hurdles. Read on to discover the potential of generative AI in healthcare.

Speed up early research and drug development with AI-enabled technology built for the cloud. Discover how to accelerate the search for the right drug candidate and progress to preclinical and clinical trials sooner.

This eBook showcases how to combine the HPC platform from Rescale with AWS infrastructure and NVIDIA GPU hardware and software – including generative AI from NVIDIA BioNeMo. You’ll find out how organizations can use accelerated computing to sift through compounds faster, rapidly narrow the field of potential drug candidates, and identify new applications for existing compounds.

Offered Free by: AWS & NVIDIA
See All Resources from: AWS & NVIDIA